Cargando…
Pancreatic stent is the best tool to prevent post-ERCP pancreatitis in high-risk patients: Is the result from recent network meta-analysis valid?
Autores principales: | Devani, Kalpit, Radadiya, Dhruvil, Brahmbhatt, Bhaumik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247900/ https://www.ncbi.nlm.nih.gov/pubmed/32490155 http://dx.doi.org/10.1055/a-1135-8883 |
Ejemplares similares
-
Trends in hospitalization, mortality, and timing of colonoscopy in patients with acute lower gastrointestinal bleeding
por: Devani, Kalpit, et al.
Publicado: (2021) -
Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
por: van Wanrooij, R. L. J., et al.
Publicado: (2019) -
Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial
por: Phillip, Veit, et al.
Publicado: (2019) -
Prevention of Post-ERCP Pancreatitis
por: Donnellan, F., et al.
Publicado: (2012) -
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021)